BIOGEN INC Profile

09062XAH6   84.95  1.59  1.84%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Default

Less than 42

 
High
 
Low
Below Average
BIOGEN is trading at 84.95 as of the 18th of January 2025, a 1.84 percent decrease since the beginning of the trading day. The bond's open price was 86.54. BIOGEN has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for BIOGEN INC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.

Moving against BIOGEN Bond

  0.59ITCI Intracellular Th TrendingPairCorr
  0.57BZUSD Brent Crude OilPairCorr
  0.47BILS SPDR Series TrustPairCorr
  0.46CLS CelesticaPairCorr
  0.44HAPR Innovator Premium IncomePairCorr
  0.42WWR Westwater ResourcesPairCorr

BIOGEN Bond Highlights

Business ConcentrationBIOGEN INC Corporate Bond, Industrial, Manufacturing (View all Sectors)
BIOGEN INC (09062XAH6) is traded in USA.

BIOGEN INC Risk Profiles

BIOGEN Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in BIOGEN without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Dashboard Now

   

Portfolio Dashboard

Portfolio dashboard that provides centralized access to all your investments
All  Next Launch Module

Other Information on Investing in BIOGEN Bond

BIOGEN financial ratios help investors to determine whether BIOGEN Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOGEN with respect to the benefits of owning BIOGEN security.